Biogen said on Thursday it had forged...
Ad Right Top
China will receive cut-price supplies of GlaxoSmithKline’s...
Celgene is officially the mystery buyer of...
June 2015 Focus: Top 100 Biotech & DTC
- Threat and Expense of Antitrust Litigation Grows in the Health Care Sector; ACE Report Identifies Due Diligence Practices to Help Mitigate Risk
- 21st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry
- The Future of Personalized Health Marketing